Product
AT193
2 clinical trials
2 indications
Indication
Hidradenitis SuppurativaIndication
PsoriasisClinical trial
A Randomized, Double-Blind, Placebo-Controlled Phase 1b Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of AT193 in the Treatment of Patients With Hidradenitis SuppurativaStatus: Completed, Estimated PCD: 2023-03-15
Clinical trial
A Randomized, Double-Blind, Placebo-Controlled Phase 1b Study Followed by an Open-Label Extension to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Topical AT193 in the Treatment of Patients With Nail PsoriasisStatus: Active (not recruiting), Estimated PCD: 2023-08-01